Postdoctoral Grant
SDH Inhibition Promotes Cardiac Regeneration in Myocardial Infarction by Reprogramming Myofibroblast Metabolism
Awarded in 2024
Cardiovascular disease remains the leading cause of death in the U.S., in part because the adult heart cannot regenerate after myocardial infarction (MI). This project explores how inhibiting succinate dehydrogenase (SDH) in myofibroblasts can reduce fibrosis and promote heart repair. Preliminary studies show SDH inhibition reprograms fibroblast metabolism, limits scar formation and boosts cardiomyocyte regeneration. By uncovering the mechanisms behind this process, the study aims to pave the way for new regenerative therapies to improve outcomes after heart attack.